Phase 1 Study for Safety and Tolerability of HL036
Clinical trial NCT02717208 · COMPLETED
Trial details
- NCT number
- NCT02717208
- Sponsor
- HanAll BioPharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2016-06-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.